Daily Respiratory Research Analysis
Three papers stand out today: a post-hoc analysis suggests rescue noninvasive ventilation for post-extubation respiratory failure may lower ICU mortality when applied with strict reintubation criteria; stool Xpert Ultra offers a practical, noninvasive diagnostic option for pediatric pulmonary TB and identifies additional cases when respiratory samples are unavailable; and a novel free-breathing 3D UTE MRI method simultaneously maps lung ventilation and perfusion without contrast or radiation, al
Summary
Three papers stand out today: a post-hoc analysis suggests rescue noninvasive ventilation for post-extubation respiratory failure may lower ICU mortality when applied with strict reintubation criteria; stool Xpert Ultra offers a practical, noninvasive diagnostic option for pediatric pulmonary TB and identifies additional cases when respiratory samples are unavailable; and a novel free-breathing 3D UTE MRI method simultaneously maps lung ventilation and perfusion without contrast or radiation, aligning well with SPECT.
Research Themes
- Rescue noninvasive ventilation in post-extubation respiratory failure
- Noninvasive diagnostics for pediatric pulmonary tuberculosis
- Radiation-free simultaneous ventilation–perfusion lung MRI
Selected Articles
1. Evaluation of the Performance of Stool Samples to Diagnose Pediatric Pulmonary Tuberculosis in Routine Care: A Cohort Study From Pakistan.
In a 650-child cohort, stool Xpert Ultra showed moderate accuracy versus microbiologically confirmed PTB, with higher sensitivity in children ≥10 years and in those with severe acute malnutrition. Importantly, it detected an additional 11% of microbiologically confirmed cases when respiratory samples were negative or unavailable, supporting stool testing as a practical noninvasive alternative in pediatric TB pathways.
Impact: This study operationalizes WHO guidance by quantifying stool Xpert Ultra performance across ages and nutrition strata in routine care, demonstrating added case detection where respiratory samples are limited.
Clinical Implications: In settings where induced sputum or gastric aspirates are difficult, stool Xpert Ultra should be incorporated into pediatric TB diagnostic algorithms—particularly for older children and those with severe acute malnutrition—to improve microbiologic confirmation.
Key Findings
- Sensitivity/specificity/accuracy of stool Xpert Ultra: 47%/88%/77% (<10 years) and 72%/73%/72% (≥10 years) versus microbiologically confirmed PTB
- Stool testing identified 11% additional microbiologically confirmed cases when respiratory samples were negative or unavailable
- Sensitivity reached 64% among severely acute malnourished children; age ≥10, female sex, SAM, and TB-consistent chest radiographs predicted positivity
Methodological Strengths
- Prospective, routine-care cohort with composite reference standard
- Age and nutritional stratification with multivariable logistic regression to identify predictors
Limitations
- Only a subset had both stool and respiratory samples, introducing potential selection/spectrum bias
- Two-center design in Pakistan may limit generalizability to other settings
Future Directions: Evaluate optimized stool collection/processing workflows, assess incremental yield/cost-effectiveness in stepped diagnostic algorithms, and validate performance in diverse epidemiologic settings.
BACKGROUND: The World Health Organization (WHO) recommends stool as an alternative respiratory sample (RS) for diagnosing pulmonary tuberculosis (PTB) in children <10 years. This study assessed stool-Xpert-Ultra diagnostic performance against microbiologically confirmed (MC-PTB) cases identified based on the composite reference standard (CRS) in children <15 years, stratified by age and nutritional status. METHODS: Children <15 years with presumptive PTB were assessed at 2 tertiary-care hospitals in Pakistan. Stools and RS were tested using Xpert MTB/RIF-Ultra (Xpert-Ultra) and culture. Using the CRS, PTB cases were MC-PTB or clinically confirmed. Nutritional status was classified using WHO criteria. Stool-Xpert-Ultra diagnostic performance was assessed against MC-PTB or positive RS-Xpert-Ultra. Logistic regression identified predictors of microbiological yields. RESULTS: Among 650 children, we obtained 587 RS, 258 stool and 195 both stool and RS. Of 650, 264 (41%) had MC and 136 (21%) had clinically confirmed PTB. Stool-Xpert-Ultra had sensitivity, specificity, and accuracy of 47%, 88%, 77%, and 72%, 73%, 72% against MC-PTB in children <10 and ≥10, respectively. Stool-Xpert-Ultra performed similarly against RS-Xpert-Ultra in each age group. Stool-Xpert-Ultra detected 11% additional MC-PTB cases when RS was negative or unavailable. Stool-Xpert-Ultra had high sensitivity (64%) in severely acute malnourished (SAM) children. Age ≥10, female, SAM and TB-consistent chest X-rays were strongly associated with stool and RS microbiological positivity. CONCLUSIONS: Stool-Xpert-Ultra demonstrated moderate sensitivity against MC-PTB in <10. It identified additional MC-PTB cases when RS was unavailable or/negative, making it a valuable noninvasive alternative, especially in children ≥10 and with SAM, where it missed fewer cases.
2. Three-dimensional Multifunctional Lung Imaging With Simultaneous Acquisition of Three-dimensional Perfusion-weighted and Ventilation-weighted Maps.
A free-breathing, noncontrast 3D UTE MRI technique simultaneously produced perfusion- and ventilation-weighted maps that highly matched SPECT, captured expected gravity dependence, and differentiated V/Q patterns across asthma, emphysema-predominant COPD, and ILD. This approach offers comprehensive, radiation-free functional lung assessment in a single acquisition.
Impact: Simultaneous, radiation-free V/Q mapping is a methodological advance that could reduce reliance on SPECT/CT and refine functional phenotyping for precision respiratory care.
Clinical Implications: If validated in larger cohorts, 3D UTE MRI could be adopted for functional assessment in COPD, asthma, and ILD, enabling V/Q phenotyping, therapy selection, and longitudinal monitoring without radiation.
Key Findings
- High structural similarity to SPECT: SSIM 0.86 (perfusion) and 0.87 (ventilation); comparable segmental CV (P>0.05)
- Strong gravity dependence correlation with SPECT (QW r=0.91, VW r=0.96)
- Clinically meaningful patterns: reduced perfusion in emphysema, increased perfusion in consolidation/GGO/fibrotic rims, V/Q mismatch in asthma vs matched defects in emphysema-predominant COPD
Methodological Strengths
- Prospective acquisition with cardiac/respiratory gating and head-to-head SPECT validation
- Repeatability assessment and cross-disease application (asthma, COPD, ILD)
Limitations
- Very small sample size (n=6) and single-center study
- Method validation focused on imaging concordance; no clinical outcomes or prognostic validation
Future Directions: Scale to multicenter cohorts, standardize acquisition/processing, and test prognostic/therapeutic utility against outcomes to support clinical adoption.
OBJECTIVES: To propose simultaneous acquisition of free-breathing, noncontrast-enhanced 3D perfusion-weighted (QW) and ventilation-weighted (VW) maps using 3D ultrashort echo-time (UTE) magnetic resonance imaging (MRI). MATERIALS AND METHODS: This prospective study included 1 healthy volunteer (25 years; female) and 5 patients (65 ± 10 y; 1 female) with diffuse pulmonary diseases [2 chronic obstructive pulmonary disease (COPD), 2 interstitial lung disease (ILD), 1 asthma], conducted between January 2022 and March 2024. Three-dimensional QW and VW maps were obtained through retrospective cardiac and respiratory gating using 3D UTE MRI on a 3T clinical scanner (Magnetom Prisma; Siemens Healthineers). QW maps were generated by voxel-wise subtraction between maximum and minimum values of 8 cardiac phase-resolved images at end-expiration, and VW maps by subtraction between end-inspiration and end-expiration images. Validation of QW maps involved: (1) assessment of coefficient of variation (CV) across 12 lung segments compared with SPECT, (2) structural similarity index measure (SSIM) analysis compared with SPECT, and (3) evaluation of anteroposterior gravity-dependence by 1D coronal slice profiles. Repeatability was tested in one healthy subject with multiple scans on separate days. In patients, regional perfusion was assessed in lesions identified on CT, and V/Q match or mismatch was evaluated in asthma and emphysema-predominant COPD. Statistical analysis included SSIM and Mann-Whitney U tests (P < 0.05). RESULTS: UTE MRI-based QW and VW maps showed high similarity with corresponding SPECT maps [SSIM: 0.86 (QW), 0.87 (VW); P >0.05 for CV across 12 lung segments]. Both maps demonstrated gravity-dependence with high correlation to SPECT (correlation coefficient: QW = 0.91, VW = 0.96). QW maps show reduced perfusion in emphysema regions and increased perfusion in regions with consolidation, ground-glass opacity (GGO), and inflammation around fibrotic cysts. Comparing asthma and emphysema-predominant COPD, QW and VW maps demonstrated V/Q mismatch in asthma but matched defects in COPD. CONCLUSIONS: Simultaneous noncontrast-enhanced 3D UTE MRI effectively provides reliable regional perfusion and ventilation information for pulmonary disease evaluation without exposure to ionizing radiation. By providing perfusion and ventilation information simultaneously, the proposed method can help to provide precise and comprehensive functional assessment of pulmonary diseases, including differentiation of pathophysiological conditions and improved evaluation of disease severity and prognosis.
3. Use of rescue noninvasive ventilation for post-extubation respiratory failure.
In a post-extubation cohort (n=147), rescue NIV had a high failure rate (58%) but was associated with lower ICU mortality versus immediate reintubation (aOR 0.31) and similar hospital mortality, when paired with prespecified reintubation criteria and IPTW/Bayesian analyses. These data challenge blanket discouragement of rescue NIV.
Impact: Findings suggest rescue NIV may be safe and beneficial when rigorously protocolized, potentially informing future guideline updates.
Clinical Implications: Clinicians may consider rescue NIV in post-extubation respiratory failure when strict reintubation thresholds and close monitoring are ensured; randomized trials are needed to confirm efficacy and define target phenotypes.
Key Findings
- Among 494 extubated patients, 147 developed respiratory failure; 83 received rescue NIV and 64 immediate reintubation
- NIV failure rate was 58% (no difference by hypoxemia vs hypercapnia/respiratory distress: 60% vs 56%)
- Rescue NIV associated with lower ICU mortality (adjusted OR 0.31; 95% CI 0.12–0.82; p=0.019) and similar hospital mortality (adjusted OR 1.01; 95% CI 0.43–2.33)
- Bayesian posterior probability that NIV reduced ICU mortality exceeded 90% across priors
Methodological Strengths
- Prespecified criteria for respiratory failure and reintubation; analysis with IPTW and Bayesian models
- Data derived from a randomized trial population with standardized follow-up
Limitations
- Post-hoc, nonrandomized allocation to rescue NIV vs reintubation introduces residual confounding
- Single-trial dataset; generalizability and protocol adherence outside trials may vary
Future Directions: Conduct pragmatic RCTs comparing protocolized rescue NIV vs immediate reintubation; identify patient phenotypes most likely to benefit and refine safety triggers.
BACKGROUND: Robust evidence supports the use of preemptive non-invasive ventilation (NIV) after extubation in selected high-risk patient cohorts. In contrast, current guidelines discourage the use of NIV as a rescue therapy for respiratory failure that develops later after extubation, based on earlier studies indicating a potential increase in hospital mortality due to delayed reintubation. Nonetheless, NIV continues to be employed in this setting. We conducted a post-hoc analysis of a randomized trial to assess the clinical outcomes of rescue NIV for post-extubation respiratory failure. METHODS: In this post-hoc analysis of a randomized trial comparing high-flow with Venturi mask oxygen in hypoxemic patients after extubation, we included those who developed post-extubation respiratory failure according to prespecified criteria; patients who received rescue NIV per physician's decision were compared to those who received direct re-intubation. Criteria for re-intubation during NIV were prespecified. Odds ratio after inverse probability of treatment weighting and posterior probabilities by Bayesian regression are reported. RESULTS: Among 494 extubated patients, 147 developed respiratory failure while receiving oxygen therapy, occurring at a median of 37 h [IQR 13-85] after extubation: 83 (57%) were treated with rescue NIV and 64 (43%) received immediate re-intubation. The rate of NIV failure was 58%, without differences between patients with hypoxemic respiratory failure and those with hypercapnia and/or respiratory distress (60% vs. 56%, p = 0.82). In the weighted cohort, the use of rescue NIV, compared to direct re-intubation, was associated with lower intensive care unit mortality (adjusted odds ratio = 0.31 [95%CI: 0.12-0.82], p = 0.019) and similar hospital mortality (adjusted odds ratio = 1.01 [95%CI: 0.43-2.33], p = 0.99). The posterior probability that NIV reduced intensive care unit mortality was > 90% across all priors. The posterior probability that NIV did not increase hospital mortality was 44% under a noninformative prior, 47% under a skeptical prior, and 39% under a pessimistic prior. CONCLUSION: Rescue NIV for post-extubation respiratory failure is associated with high failure rates; however, when applied with well-defined criteria for reintubation, it does not appear to be clearly associated with increases in hospital mortality. A randomized trial to re-evaluate the efficacy of rescue NIV for post-extubation respiratory failure is warranted. CLINICAL TRIAL REGISTRATION: Registered at clinicaltrials.gov (NCT02107183) on April 8th, 2014.